top of page
Search


When Innovation Doesn’t Reach Patients: The true cost of Europe’s access crisis is measured in lives
Despite Europe’s reputation for scientific leadership, the truth is that patients across the continent are waiting longer, and often in...
NíoSync
3 days ago2 min read


Ireland Needs to Rethink Its Biopharma Strategy: From Global Manufacturer to Global Owner
Ireland's biopharma sector is a world-class success story, but what worked in the past will not lead to future success. We've spent...
NíoSync
Jun 53 min read
bottom of page